Margaret Dugan - Aug 9, 2023 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role: Chief Medical Officer
Signature: /s/ Donald Shum, as attorney-in-fact for Margaret Dugan
Stock symbol: SDGR
Transactions as of: Aug 9, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/10/2023, 04:38 PM
Previous filing: Aug 3, 2023
Next filing: Mar 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SDGR	Common Stock	Award	$0	+15K		$0.00	15K	Aug 9, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SDGR	Stock Option (right to buy)	Award	$0	+90K		$0.00	90K	Aug 9, 2023	Common Stock	90K	$39.89	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units ("RSUs") under the Issuer's 2021 Inducement Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on August 9, 2023 and will vest in equal installments on each of October 15, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.
F2	Includes 15,000 unvested RSUs.
F3	The option was granted on August 9, 2023 under the Issuer's 2021 Inducement Equity Incentive Plan. The shares underlying the option are scheduled to vest with respect to 25% of the shares on July 31, 2024 and the remainder are scheduled to vest in equal monthly installments through July 31, 2027.